LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
98,900
-1,600 (-1.59%)
May 9, 2025, 3:30 PM KST
44.17%
Market Cap 3.59T
Revenue (ttm) 125.90B
Net Income (ttm) 7.80B
Shares Out 36.28M
EPS (ttm) 224.00
PE Ratio 460.03
Forward PE 29.43
Dividend n/a
Ex-Dividend Date n/a
Volume 242,222
Average Volume 290,790
Open 100,900
Previous Close 100,500
Day's Range 98,600 - 102,000
52-Week Range 60,600 - 143,600
Beta 1.36
RSI 42.77
Earnings Date May 13, 2025

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 163
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.